Shares of ImmuPharma plc (LON:IMM – Get Free Report) were down 2.9% during trading on Wednesday . The company traded as low as GBX 2.82 ($0.03) and last traded at GBX 2.99 ($0.04). Approximately 2,807,457 shares changed hands during trading, a decline of 86% from the average daily volume of 19,594,438 shares. The stock had previously closed at GBX 3.08 ($0.04).
ImmuPharma Stock Up 10.5 %
The stock has a market capitalization of £16.57 million, a price-to-earnings ratio of -397.90 and a beta of 1.53. The company’s fifty day simple moving average is GBX 1.71 and its 200 day simple moving average is GBX 1.72.
ImmuPharma Company Profile
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Featured Articles
- Five stocks we like better than ImmuPharma
- Buy P&G Now, Before It Sets A New All-Time High
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Short Selling: How to Short a Stock
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- How to Use the MarketBeat Excel Dividend Calculator
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
